Georgia vs Iran, Islamic Republic of: Tuberculosis treatment success rate
Georgia
85.0%
in 2023
Iran, Islamic Republic of
85.0%
in 2023
Georgia rank
89th
Iran, Islamic Republic of rank
89th
Tuberculosis treatment success rate over time
- Georgia
- Iran, Islamic Republic of
How they compare
Georgia currently reports 85.0% against 85.0% in Iran, Islamic Republic of, a difference of 0.0%.
The two have swapped places 2 times across 28 shared years of data; in 1996 it was Iran, Islamic Republic of ahead.
Georgia ranks 89th and Iran, Islamic Republic of ranks 89th of 206 countries.
Across the 4 decades both report, Georgia averaged higher in 1 and Iran, Islamic Republic of in 3.
Head to head by decade
| Decade | Georgia | Iran, Islamic Republic of | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 69.2% | 82.5% | 13.2% | Iran, Islamic Republic of |
| 2000s | 72.3% | 82.9% | 10.6% | Iran, Islamic Republic of |
| 2010s | 82.8% | 85.8% | 3.0% | Iran, Islamic Republic of |
| 2020s | 86.5% | 84.0% | 2.5% | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Georgia or Iran, Islamic Republic of?
- Georgia, at 85.0% against 85.0% in Iran, Islamic Republic of as of 2023.
- What is the difference in tuberculosis treatment success rate between Georgia and Iran, Islamic Republic of?
- 0.0%, with Georgia ahead.
- How many years of comparable data are there for Georgia and Iran, Islamic Republic of?
- 28 years are reported by both, from 1996 to 2023.
- How do Georgia and Iran, Islamic Republic of rank globally for tuberculosis treatment success rate?
- Georgia ranks 89th and Iran, Islamic Republic of ranks 89th of 206 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.